Related Experiment Video

Updated: May 8, 2026

Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms
11:58

Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms

Published on: August 11, 2015

[Nebivolol in treatment of multiple cerebral aneurysms]

Csaba Oláh1, Béla Demeter, Alex Szólics

  • 1Borsod-Abaúj-Zemplén Megyei Kórház es Egyetemi Oktató Kórház, Idegsebészeti Osztály, Miskolc. olahcs@gmail.com

Ideggyogyaszati Szemle
|August 27, 2013
PubMed

Insights

Nebivolol effectively controlled blood pressure in patients with multiple aneurysms after subarachnoid hemorrhage. This medication helped prevent increases in silent aneurysm size, suggesting its utility in managing complex cerebrovascular conditions.

Area of Science:

  • Neurosurgery
  • Cardiology
  • Pharmacology

Background:

  • Investigating nebivolol's impact on blood pressure control post-subarachnoid hemorrhage in patients with multiple aneurysms.
  • Assessing the role of antihypertensive therapy in preventing re-bleeding and silent aneurysm expansion.

Observation:

  • Patients received endovascular intervention for bleeding aneurysms, with nebivolol administered for long-term blood pressure management.
  • Continuous monitoring of blood pressure and aneurysm size via catheter-angiography was performed.

Findings:

  • Nebivolol maintained blood pressure within the normal range, preventing hypertensive spikes.
  • No increase in the size of untreated (silent) aneurysms was observed.
  • Endovascularly treated aneurysms showed stable morphology on follow-up imaging.

Implications:

  • Strict blood pressure control is crucial after treating ruptured aneurysms in patients with multiple aneurysms to prevent rupture of other aneurysms.
  • Nebivolol, with its sustained 24-hour effect, appears to be a suitable antihypertensive agent for this patient population.
  • This study highlights the importance of long-term antihypertensive management in reducing risks associated with multiple cerebral aneurysms.
Abstract

More Related Videos

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...